Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial Comparing Two Doses of VF001-DP to Placebo as an Adjunct to Standard Care in Patients With Chronic Venous Leg Ulcers

NCT02973893 is registered in ClinicalTrials.gov with Factor Therapeutics Ltd. as lead sponsor.

NCT NCT02973893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02973893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial Comparing Two Doses of VF001-DP to Placebo as an Adjunct to Standard Care in Patients With Chronic Venous Leg Ulcers
Lead sponsor
Factor Therapeutics Ltd.
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2016
Completion date
February 28, 2019
Enrollment
156 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, leg ulcer, pathologic processes, skin diseases, skin ulcer, ulcer, varicose ulcer, vascular diseases